Stubbs et al - TMAO and CV Outcomes in EVOLVE_CJASN.pdf (541.32 kB)
Download fileStubbs et al - TMAO and CV Outcomes in EVOLVE_CJASN.pdf
journal contribution
posted on 2019-03-14, 17:33 authored by Jason Stubbs, Margaret Stedman, Sai Liu, Jin Long, Yoko Franchetti, Raymond West III, Alex Prokopienko, Jonathan Mahnken, Glenn Chertow, Tom NolinThe data demonstrates that baseline levels of TMAO, a circulating compound derived from byproducts of intestinal bacteria, do not predict cardiovascular endpoints in patients with end-stage kidney disease.